Standard BioTools
LAB
LAB
112 hedge funds and large institutions have $249M invested in Standard BioTools in 2020 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 36 increasing their positions, 40 reducing their positions, and 20 closing their positions.
Holders
112
Holders Change
+9
Holders Change %
+8.74%
% of All Funds
2.3%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
30
Increased
36
Reduced
40
Closed
20
Calls
$468K
Puts
$127K
Net Calls
+$341K
Net Calls Change
+$319K
Top Buyers
1 |
O
1
OrbiMed
New York
|
$11.7M |
2 |
TM
2
Tikvah Management
Charlotte,
North Carolina
|
$5.01M |
3 |
3
Millennium Management
New York
|
$7.46M |
4 |
PVI
4
Pura Vida Investments
New York
|
$3.39M |
5 |
5
UBS Group
Zurich,
Switzerland
|
$3.82M |